Showing results (821-830 of 973) with videos related to
Sort By:
Pageof 98
Malaria Journal|March 15, 2017
Rhesus macaque and mouse models for down-selecting circumsporozoite protein based malaria vaccines differ significantly in immunogenicity and functional outcomesTimothy W Phares, Anthony D May, Christopher J Genito, et al.Journal of Biomechanical Engineering|August 3, 2000
Mechanical properties of a biodegradable bone regeneration scaffoldB D Porter, J B Oldham, S L He, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 6, 2000
Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, KenyaF S Rana, M P Hawken, C Mwachari, et al.Orphanet Journal of Rare Diseases|September 5, 2022
Phenotypic expression of swallowing function in Niemann-Pick disease type C1Beth I Solomon, Andrea M Muñoz, Ninet Sinaii, et al.Journal of Activity, Sedentary and Sleep Behaviors|October 14, 2024
24-hour movement behavior adherence and associations with health outcomes: an umbrella reviewChelsea L Kracht, Sarah Burkart, Claire I Groves, et al.Molecular Genetics and Metabolism|July 16, 2013
A somatic cell defect is associated with the onset of neurological symptoms in a lysosomal storage diseaseJorge L Rodriguez-Gil, Denise M Larson, Christopher A Wassif, et al.Biomarker Insights|October 10, 2022
Glycerophosphoinositol is Elevated in Blood Samples From CLN3 Δex7-8 pigs, Cln3 Δex7-8 Mice, and CLN3-Affected IndividualsJon J Brudvig, Vicki J Swier, Tyler B Johnson, et al.Journal of Neurodevelopmental Disorders|April 8, 2016
Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an updateAudrey Thurm, Elaine Tierney, Cristan Farmer, et al.Scientific Reports|July 26, 2017
NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controlsFay Probert, Victor Ruiz-Rodado, Danielle Te Vruchte, et al.Plos One|September 28, 2022
Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological functionMatthew J Strauss, Katherine D Porter, Pamela M Quizon, et al.Pageof 98